Here, we investigated the potentials and mechanisms of action of Ashwagandha derived two steroidal lactone bioactive withanolides, Withanone (Wi-N) and Withaferin-A (Wi-A), for treatment of aberrant EGFR-derived lung cancers. This evidence concerns the gene EGFR and lung cancer.